Diet and nutritionWeight gain during menopause? It could be insulin and hormones, not overeating!
What do Natural Therapy Specialists write?
A slower metabolism may accompany weight gain during menopause, while mood swings can encourage snacking.
Carbohydrates raise insulin levels, which signals the body to store energy; Bracia Rodzeń links higher carbohydrate intake with weight gain.
Thyroid hormones stimulate basal metabolic rate.
Estrogens are linked with the development of cellulite, while progesterone is linked with water retention in connective and fatty tissue.
Thomas E. Levy attributes fat gain to sugars and carbohydrates, not dietary fats.
Thomas E. Levy links insulin spikes after eating carbohydrates with increased hunger and overeating.
Nathan S. Bryan links dysfunction in cells of the digestive system with weight gain, and insufficient energy production in cells of the endocrine system with hormone disorders.
What does scientific research from PubMed · Europe PMC say?
We selected 8 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 83 801.
Aim of the study: Polycystic ovary syndrome (PCOS) is a common endocrine disorder that occurs in women of reproductive age. Hyperandrogenism, polycystic ovaries, chronic anovulation, and metabolic abnormalities are common features of PCOS.
Results: These hormones are related to metabolic disorders, such as diabetes and insulin resistance, overweight and obesity, infertility, and disturbed menstrual cycles in patients with PCOS. Pathological changes in these hormones, such as increased insulin, reduced GH, increased ghrelin, and leptin resistance, result in a higher prevalence of diabetes and obesity in women with PCOS. Reduced GH, increased LEAP-2 levels, high basal LH, an increased LH/FSH ratio, high androgen levels, and low estrogen levels are found in PCOS and are linked to infertility. This narrative review aims to clarify changes in hormone profiles, such as insulin, GH, LH, FSH, androgens, estrogen, progesterone, ghrelin, LEAP-2, asprosin, and subfatin, in PCOS, which may reveal new targets for better diagnosis and treatment of PCOS.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: This chapter has reviewed the evidence that obesity is characterized by distinct patterns of hormonal changes related both to the degree of obesity and to the distribution of fat tissue. Many of these changes are also seen in people with Cushing's syndrome and polycystic ovary syndrome, particularly hyperinsulinaemia and changes in adrenocortical activity and sex steroid secretion and binding.
Results: Upper-body obesity is characterized by large fat cells with higher LPL activity, elevated basal and stimulated lipolysis, but a low antilipolytic effect of insulin. Results from preliminary investigations of potential candidate genes suggest a possible genetic basis for the hyperinsulinaemia/insulin resistance found in upper-body obesity, but further studies involving larger numbers of people are needed to confirm this. It is hoped that findings from such molecular studies will shed additional light on both the genetic background of obesity and the complex hormonal changes seen at the tissue level. This should help confirm a unifying theory for the causal factors associated with obesity and related conditions.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Obesity is a major global epidemic, with over 300 million people with obesity worldwide and nearly 1 billion adults who are overweight. Being overweight carries significant health risks, reduces quality of life, and impairs socioeconomic success, with profound consequences for health expenditure.
Results: It remains unproven whether their hyperghrelinemia or other gut-hormone abnormalities contribute to the hyperphagia in PWS, in addition to brain defects. Postmortem studies of the human hypothalamus and the development of animal models of PWS can also provide insight into the pathophysiology of abnormal feeding behavior. Changes in orexigenic NPY and AGRP hypothalamic neurons, or anorexigenic oxytocin neurons, have been found in illness and PWS. Functional neuroimaging studies using PET and fMRI will also allow us to tease apart the hormonal and brain pathways responsible for controlling human appetite, and their defects in obesity.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Several endocrine abnormalities have been reported in obesity. Some of these abnormalities are considered causes of obesity, whereas others are considered secondary effects of obesity and usually return to normal after weight loss.
Results: Also, several endocrine diseases have obesity as one of their clinical manifestations. Hypothyroidism, Cushing's syndrome, GH and testosterone deficiency, polycystic ovary syndrome, insulinoma, hypothalamic lesions, and genetic syndromes often present with obesity. In most of these conditions, appropriate treatment of the underlying disease results in weight loss. In addition, fat cells have been found to be endocrine organs that produce several bioactive peptides involved in regulating fat-cell function.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Leptin is a hormone secreted by fat cells, the stomach, and the placenta. Age, sex, onset of puberty, and food intake are the most important physiological factors that determine leptin concentration.
Results: Age, sex, onset of puberty, and food intake are the most important physiological factors that determine leptin concentration. Leptin secretion has been shown to be regulated by other hormones such as insulin, glucocorticoids, and sex steroids. Leptin plays an important role in regulating hunger and satiety, as well as in normal sexual maturation. Some studies in people with obesity have shown promising results with leptin administration.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Over the past 40 years, the prevalence of obesity has risen dramatically, reaching epidemic proportions. By 2030, the number of people affected by obesity will reach 1.12 billion worldwide.
Results: The gut microbiota plays an important role in various metabolic conditions, including obesity and type 2 diabetes, and influences host metabolism through interactions with enteroendocrine cells that modulate incretin secretion. Gut microbiota metabolites, such as short-chain fatty acids (SCFAs) and indole, directly stimulate the release of incretins from colonic enteroendocrine cells, affecting satiety and food intake. Moreover, bariatric surgery and incretin-based therapies are associated with increased gut bacterial richness and diversity. Understanding the role of incretins, gut microbiota, and their metabolites in regulating metabolic processes is crucial to developing effective strategies for managing obesity and its associated conditions.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Severe obesity is associated with hormonal imbalances, hyperandrogenism, and insulin resistance, all of which adversely affect reproductive physiology. Metabolic and bariatric surgery (MBS) leads to lasting weight loss and metabolic improvement, but its effects on ovarian reserve markers and reproductive hormones in women of reproductive age remain incompletely characterized.
Results: BMI decreased from 42.38 ± 1.41 to 25.65 ± 0.34 kg/m² at 12 months (p < 0.001). AMH declined from 3.13 ± 0.17 to 2.24 ± 0.44 ng/mL; AFC fell from 11.22 ± 1.60 to 7.16 ± 1.63 (right ovary) and from 11.09 ± 1.30 to 6.19 ± 0.86 (left ovary). FSH, LH, and estradiol increased; SHBG nearly doubled (36.26 → 63.77 nmol/L); total testosterone decreased markedly (27.76 → 9.34 ng/dL); FAI fell from 2.73 ± 0.85 to 0.53 ± 0.19; HOMA-IR declined from 3.94 ± 0.46 to 1.66 ± 0.56 (all p < 0.001). Spearman correlations among changes showed inverse associations between ΔSHBG and ΔFAI (ρ = -0.420, p = 0.017), and between ΔHOMA-IR and Δtotal testosterone (ρ = -0.374, p = 0.035). Sleeve gastrectomy was associated with marked improvements in insulin resistance and androgen profiles, accompanied by progressive increases in SHBG and reductions in FAI, AMH, and AFC over 12 months.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Obesity affects 2.5 billion adults, disrupting the hypothalamic-pituitary-ovarian (HPO) axis through adipokine imbalance and aromatase activity. This causes hormonal dysregulation, infertility, and pregnancy risks. Bariatric surgery can restore hormonal balance and improve menstrual regularity. This study evaluates changes in reproductive hormones and cycle regularity over six months after bariatric surgery in Egyptian women with obesity.
Results: Bariatric surgery resulted in a highly significant reduction in body weight and BMI over the six-month follow-up period (p < 0.001). Significant hormonal changes were observed, including increased levels of FSH (p < 0.001) and LH (p = 0.001), a decreased LH/FSH ratio (p = 0.005), and marked reductions in estrogen and progesterone concentrations (p < 0.001). While AMH levels remained stable (p = 0.6), menstrual regularity improved significantly from 20% at baseline to 53.3% after surgery (p = 0.001). Furthermore, the degree of weight loss was significantly and positively correlated with postoperative FSH and LH levels. The interventions were generally well tolerated, with 82.4% of participants reporting no postoperative complications. No significant differences in improvements in weight or hormonal profiles were noted between patients with and without PCOS.
“Not stated” does not mean nobody paid — the database does not always record it.
What do orthomolecular medicine doctors write?
Sources (17)
- Andrzej Frydrychowski — Menopauza - jak nie oszaleć i pozostać kobietą?
- Bracia Rodzeń — Bracia Rodzeń
- Henryk Różański — Choroba Hashimoto, czyli przewlekłe autoimmunologiczne zapalenie tarczycy, część 1.
- Henryk Różański — Powstawanie Cellulitis – cellulit
- Thomas E. Levy — Dr. Thomas Levy
- Nathan S. Bryan — The Energy of Life - How Do We Capture & Optimize Our Energy Output?
- Hormonal changes in PCOS. · J Endocrinol 2024
- Hormones and obesity. · Baillieres Clin Endocrinol Metab 1994
- The hypothalamus, hormones, and hunger: alterations in human obesity and illness. · Prog Brain Res 2006
- Obesity and endocrine disease. · Endocrinol Metab Clin North Am 2003
- [Leptin]. · Rev Invest Clin 2002
- Incretin hormones, obesity and gut microbiota. · Peptides 2024
- Impact of Sleeve Gastrectomy on Obesity Indices, Reproductive Hormones, and Ovarian Reserve Markers: A 12-Month Prospective Study. · Obes Surg 2026
- Impact of Bariatric Surgery on Reproductive Hormones and Menstrual Regularity in Women with Obesity. · Obes Surg 2026
- Orthomolecular Medicine News Service — Understanding and Addressing Vitamin D Resistance: A Comprehensive Approach Integrating Genetic, Environmental, and Nutritional Factors
- Orthomolecular Medicine News Service — The ICV Axis: A Practical, Clinically Actionable Breakthrough for BHRT and Metabolic Medicine
- Orthomolecular Medicine News Service — Vitamin C and Cortisol: Synergistic Infection and Toxin Defense
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.